Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
See Josephs (doi:10.1093/brain/awx367) for a scientific commentary on this article.In many neurodegenerative disorders, familial forms have provided important insights into the pathogenesis of their corresponding sporadic forms. The first mutations associated with frontotemporal lobar degeneration (FTLD) were found in the microtubule-associated protein tau (MAPT) gene on chromosome 17 in families with frontotemporal degeneration and parkinsonism (FTDP-17). However, it was soon discovered that 50% of these families had a nearby mutation in progranulin. Regardless, the original FTDP-17 nomenclature has been retained for patients with MAPT mutations, with such patients currently classified independently from the different sporadic forms of FTLD with tau-immunoreactive inclusions (FTLD-tau). The separate classification of familial FTLD with MAPT mutations implies that familial forms cannot inform on the pathogenesis of the different sporadic forms of FTLD-tau. To test this assumption, this study pathologically assessed all FTLD-tau cases with a known MAPT mutation held by the Sydney and Cambridge Brain Banks, and compared them to four cases of four subtypes of sporadic FTLD-tau, in addition to published case reports. Ten FTLD-tau cases with a MAPT mutation (K257T, S305S, P301L, IVS10+16, R406W) were screened for the core differentiating neuropathological features used to diagnose the different sporadic FTLD-tau subtypes to determine whether the categorical separation of MAPT mutations from sporadic FTLD-tau is valid. Compared with sporadic cases, FTLD-tau cases with MAPT mutations had similar mean disease duration but were younger at age of symptom onset (55 ± 4 years versus 70 ± 6 years). Interestingly, FTLD-tau cases with MAPT mutations had similar patterns and severity of neuropathological features to sporadic FTLD-tau subtypes and could be classified into: Pick's disease (K257T), corticobasal degeneration (S305S, IVS10+16, R406W), progressive supranuclear palsy (S305S) or globular glial tauopathy (P301L, IVS10+16). The finding that the S305S mutation could be classified into two tauopathies suggests additional modifying factors. Assessment of our cases and previous reports suggests that distinct MAPT mutations result in particular FTLD-tau subtypes, supporting the concept that they are likely to inform on the varied cellular mechanisms involved in distinctive forms of sporadic FTLD-tau. As such, FTLD-tau cases with MAPT mutations should be considered familial forms of FTLD-tau subtypes rather than a separate FTDP-17 category, and continued research on the effects of different mutations more focused on modelling their impact to produce the very different sporadic FTLD-tau pathologies in animal and cellular models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationMutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Criteria for the diagnosis of corticobasal degeneration
Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., Boxer, A. L., Dickson, D. W., Grossman, M., Hallett, M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0fd1 · Cited by 1,904 · cited 2×
“…other FTLD-tau subtypes, they do not discriminate sporadic CBD cases from those with MAPT mutations (Dickson et al., 2002) and therefore recent clinical criteria exclude cases with a family history or MAPT mutation from a diagnosis of probable (although not possible) CBD (Armstrong et al., 2013).”
BackgroundCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512 · cited 10×
“In contrast, some authors have retained the original FTDP-17 nomenclature for patients with mutations in MAPT and these are currently classified separately from the sporadic forms of FTLD with tau-immunoreactive inclusions (FTLD-tau, Fig.”
BackgroundInfluentialMutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474 · cited 1×
“The first mutations associated with FTLD were found in the microtubule-associated protein tau (MAPT) gene on chromosome 17 in families with familial frontotemporal degeneration and parkinsonism (FTDP-17) (Hutton et al., 1998; Poorkaj et al., 1998; Spillantini et al., 1998).”
BackgroundSelf-citationPrimary age-related tauopathy (PART): a common pathology associated with human aging
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467 · cited 2×
“Argyrophilic grain disease (AGD) and neurofibrillary tangle predominant dementia (NFTPD), which includes primary age-related tauopathy (PART) (Crary et al., 2014) are further recognized subtypes, but comprise a small proportion of FTLDtau cases (Jellinger and Attems, 2007; Josephs et al., 2011).”
BackgroundTau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374 · cited 10×
“In contrast, some authors have retained the original FTDP-17 nomenclature for patients with mutations in MAPT and these are currently classified separately from the sporadic forms of FTLD with tau-immunoreactive inclusions (FTLD-tau, Fig.”
BackgroundInfluentialTau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
Self-citationCairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110
Self-citationOffice of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration
Dickson, D. W., Bergeron, C., Chin, S. S., Duyckaerts, C., Horoupian, D., Ikeda, K., Jellinger, K., Lantos, P. L., Lippa, C. F., Mirra, S. S., et al. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.11.935 · Cited by 724 · cited 8×
“Selection of brain regions of interest was based on key areas routinely sampled for standard FTLD neuropathological assessment (Table 2) (Hauw et al., 1994; Dickson et al., 2002; Cairns et al., 2007; Ahmed et al., 2013).”
BackgroundInfluential
Research works printed but not linked: 87
- Ahmed, 2013, Globular glial tauopathies (GGT): consensus recommendations, Acta Neuropathol, 126, 537, 10.1007/s00401-013-1171-0 · DOI · Paper page
- Allen, 2016, Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci, Acta Neuropathol, 132, 197, 10.1007/s00401-016-1576-7 · DOI · Paper page
- Anfossi, 2011, Compound heterozygosity of 2 novel MAPT mutations in frontotemporal dementia, Neurobiol Aging, 32, 757e1, 10.1016/j.neurobiolaging.2010.12.013 · DOI
- Aoyagi, 2007, Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau, J Biol Chem, 282, 20309, 10.1074/jbc.M611876200 · DOI · Paper page
- Boeve, 2011, The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study, J Mol Neurosci, 45, 350, 10.1007/s12031-011-9624-1 · DOI
- Borroni, 2010, VEGF haplotypes are associated with increased risk to progressive supranuclear palsy and corticobasal syndrome, J Alzheimers Dis, 21, 87, 10.3233/JAD-2010-091615 · DOI
- Bronner, 2005, Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology, Brain, 128, 2645, 10.1093/brain/awh591 · DOI · Paper page
- Burrell, 2016, Expanding the phenotypic associations of globular glial tau subtypes, Alzheimers Dement, 4, 6
- Chahine, 2014, Corticobasal syndrome: Five new things, Neurol Clin Pract, 4, 304, 10.1212/CPJ.0000000000000026 · DOI
- Chaunu, 2013, Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389R, J Alzheimers Dis, 37, 769, 10.3233/JAD-130413 · DOI
- Chiu, 2010, Survival in progressive supranuclear palsy and frontotemporal dementia, J Neurol Neurosurg Psychiatry, 81, 441, 10.1136/jnnp.2009.195719 · DOI · Paper page
- D'Souza, 2006, Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K, J Biol Chem, 281, 2460, 10.1074/jbc.M505809200 · DOI · Paper page
- de Yebenes, 1995, Familial progressive supranuclear palsy. Description of a pedigree and review of the literature, Brain, 118, 1095, 10.1093/brain/118.5.1095 · DOI · Paper page
- Delisle, 1999, A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy, Acta Neuropathol, 98, 62, 10.1007/s004010051052 · DOI · Paper page
- Deramecourt, 2012, Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S, J Alzheimers Dis, 31, 741, 10.3233/JAD-2012-120160 · DOI · Paper page
- Domoto-Reilly, 2017, Unusually long duration and delayed penetrance in a family with FTD and mutation in MAPT (V337M), Am J Med Genet B Neuropsychiatr Genet, 174, 70, 10.1002/ajmg.b.32443 · DOI
- Donker Kaat, 2009, Familial aggregation of parkinsonism in progressive supranuclear palsy, Neurology, 73, 98, 10.1212/WNL.0b013e3181a92bcc · DOI · Paper page
- Ferrari, 2014, Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy, Neurobiol Aging, 35, 1514 e1, 10.1016/j.neurobiolaging.2014.01.010 · DOI
- Ferrer, 2014, Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression, J Neuropathol Exp Neurol, 73, 81, 10.1097/NEN.0000000000000030 · DOI · Paper page
- Fujioka, 2015, Three sib-pairs of autopsy-confirmed progressive supranuclear palsy, Parkinsonism Relat Disord, 21, 101, 10.1016/j.parkreldis.2014.10.028 · DOI · Paper page
- Gasca-Salas, 2016, Characterization of movement disorder phenomenology in genetically proven, familial frontotemporal lobar degeneration: a systematic review and meta-analysis, PLoS One, 11, e0153852, 10.1371/journal.pone.0153852 · DOI
- Gauthier-Kemper, 2011, The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner, J Cell Biol, 192, 647, 10.1083/jcb.201007161 · DOI · Paper page
- Ghetti, 2000, Progress in hereditary tauopathies: a mutation in the Tau gene (G389R) causes a Pick disease-like syndrome, Ann N Y Acad Sci, 920, 52, 10.1111/j.1749-6632.2000.tb06905.x · DOI
- Ghetti, 2015, Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging, Neuropathol Appl Neurobiol, 41, 24, 10.1111/nan.12213 · DOI · Paper page
- Goldman, 2005, Comparison of family histories in FTLD subtypes and related tauopathies, Neurology, 65, 1817, 10.1212/01.wnl.0000187068.92184.63 · DOI · Paper page
- Grijalvo-Perez, 2014, Corticobasal degeneration, Semin Neurol, 34, 160, 10.1055/s-0034-1381734 · DOI
- Gunawardana, 2015, The human tau interactome: binding to the ribonucleoproteome, and impaired binding of the proline-to-leucine mutant at position 301 (P301L) to chaperones and the proteasome, Mol Cell Proteomics, 14, 3000, 10.1074/mcp.M115.050724 · DOI · Paper page
- Halliday, 2006, Neuropathology in the S305S tau gene mutation, Brain, 129, E40, 10.1093/brain/awh720 · DOI
- Hauw, 1994, Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy), Neurology, 44, 2015, 10.1212/WNL.44.11.2015 · DOI · Paper page
- Hayashi, 2002, Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation, Ann Neurol, 51, 525, 10.1002/ana.10163 · DOI · Paper page
- Hodges, 2003, Survival in frontotemporal dementia, Neurology, 61, 349, 10.1212/01.WNL.0000078928.20107.52 · DOI · Paper page
- Hogg, 2003, The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy, Acta Neuropathol, 106, 323, 10.1007/s00401-003-0734-x · DOI
- Hoglinger, 2011, Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy, Nat Genet, 43, 699, 10.1038/ng.859 · DOI · Paper page
- Irwin, 2016, Deep clinical and neuropathological phenotyping of Pick disease, Ann Neurol, 79, 272, 10.1002/ana.24559 · DOI · Paper page
- Ittner, 2008, Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia, Proc Natl Acad Sci USA, 105, 15997, 10.1073/pnas.0808084105 · DOI · Paper page
- Ittner, 2015, FTD and ALS–translating mouse studies into clinical trials, Nat Rev Neurol, 11, 360, 10.1038/nrneurol.2015.65 · DOI · Paper page
- Jellinger, 2007, Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease, Acta Neuropathol, 113, 107, 10.1007/s00401-006-0156-7 · DOI
- Jiang, 2003, Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta, J Biol Chem, 278, 18997, 10.1074/jbc.M301800200 · DOI · Paper page
- Josephs, 2011, Neuropathological background of phenotypical variability in frontotemporal dementia, Acta Neuropathol, 122, 137, 10.1007/s00401-011-0839-6 · DOI · Paper page
- Jung, 2012, Phenotypic variation of autosomal-dominant corticobasal degeneration, Eur Neurol, 67, 142, 10.1159/000334731 · DOI
- Katsuse, 2003, 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy, Acta Neuropathol, 106, 251, 10.1007/s00401-003-0728-8 · DOI
- Kondo, 2004, Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA, Genes Cells, 9, 121, 10.1111/j.1356-9597.2004.00709.x · DOI · Paper page
- Kouri, 2011, Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome, Brain, 134, 3264, 10.1093/brain/awr234 · DOI · Paper page
- Kouri, 2014, Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration, Acta Neuropathol, 127, 271, 10.1007/s00401-013-1193-7 · DOI · Paper page
- Kovacs, 2008, MAPT S305I mutation: implications for argyrophilic grain disease, Acta Neuropathol, 116, 103, 10.1007/s00401-007-0322-6 · DOI
- Kovacs, 2013, Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium, Neuropathol Appl Neurobiol, 39, 166, 10.1111/j.1365-2990.2012.01272.x · DOI · Paper page
- Lang, 2003, Corticobasal degeneration: selected developments, Mov Disord, 18 Suppl 6, S51, 10.1002/mds.10563 · DOI
- Lashley, 2015, An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations, Neuropathol Appl Neurobiol, 41, 858, 10.1111/nan.12250 · DOI · Paper page
- Le Ber, 2013, C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing, J Alzheimers Dis, 34, 485, 10.3233/JAD-121456 · DOI · Paper page
- Lee, 2017, Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration, Acta Neuropathol, 134, 65, 10.1007/s00401-017-1679-9 · DOI · Paper page
- Lippa, 2000, Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation, Ann Neurol, 48, 850, 10.1002/1531-8249(200012)48:6<850::AID-ANA5>3.0.CO;2-V · doi:10.1002/1531-8249(200012)48:6<850::aid-ana5>3.0.co;2-v
- Maltete, 2016, Adult-onset stereotypical motor behaviors, Rev Neurol, 172, 477, 10.1016/j.neurol.2016.07.002 · DOI
- Morris, 2003, Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP, Neurology, 61, 102, 10.1212/01.WNL.0000072325.27824.A5 · DOI · Paper page
- Murrell, 1999, Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits, J Neuropathol Exp Neurol, 58, 1207, 10.1097/00005072-199912000-00002 · DOI · Paper page
- Neumann, 2001, Pick's disease associated with the novel Tau gene mutation K369I, Ann Neurol, 50, 503, 10.1002/ana.1223 · DOI · Paper page
- Ouchi, 2014, Pathology and sensitivity of current clinical criteria in corticobasal syndrome, Mov Disord, 29, 238, 10.1002/mds.25746 · DOI
- Pickering-Brown, 2000, Pick's disease is associated with mutations in the tau gene, Ann Neurol, 48, 859, 10.1002/1531-8249(200012)48:6<859::AID-ANA6>3.0.CO;2-1 · doi:10.1002/1531-8249(200012)48:6<859::aid-ana6>3.0.co;2-1
- Pickering-Brown, 2004, Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene, Brain, 127, 1415, 10.1093/brain/awh147 · DOI · Paper page
- Piguet, 2011, Clinical phenotypes in autopsy-confirmed Pick disease, Neurology, 76, 253, 10.1212/WNL.0b013e318207b1ce · DOI · Paper page
- Po, 2014, Heritability in frontotemporal dementia: more missing pieces?, J Neurol, 261, 2170, 10.1007/s00415-014-7474-9 · DOI
- Poorkaj, 2002, An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype, Ann Neurol, 52, 511, 10.1002/ana.10340 · DOI · Paper page
- Rademakers, 2013, Advances in understanding the molecular basis of frontotemporal dementia, Nature Rev Neurol, 9, 240, 10.1038/nrneurol.2013.76 · DOI
- Reed, 2001, Phenotypic correlations in FTDP-17, Neurobiol Aging, 22, 89, 10.1016/S0197-4580(00)00202-5 · DOI · Paper page
- Rizzini, 2000, Tau gene mutation K257T causes a tauopathy similar to Pick's disease, J Neuropathol Exp Neurol, 59, 990, 10.1093/jnen/59.11.990 · DOI · Paper page
- Rohrer, 2011, Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration, Brain, 134, 2565, 10.1093/brain/awr198 · DOI · Paper page
- Rojo, 1999, Clinical genetics of familial progressive supranuclear palsy, Brain, 122, 1233, 10.1093/brain/122.7.1233 · DOI · Paper page
- Ros, 2005, A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy, Arch Neurol, 62, 1444, 10.1001/archneur.62.9.1444 · DOI · Paper page
- Ros, 2008, Parkin polymorphisms in progressive supranuclear palsy, J Neurol Sci, 268, 176, 10.1016/j.jns.2007.10.022 · DOI
- Rosso, 2002, A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's disease, Ann Neurol, 51, 373, 10.1002/ana.10140 · DOI · Paper page
- Sanchez, 2002, Progressive supranuclear palsy and tau hyperphosphorylation in a patient with a C212Y parkin mutation, J Alzheimers Dis, 4, 399, 10.3233/JAD-2002-4506 · DOI
- Scaravilli, 2005, Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting, Mov Disord, 20 Suppl 12, S21, 10.1002/mds.20536 · DOI · Paper page
- Schellenberg, 2012, The genetics and neuropathology of Alzheimer's disease, Acta Neuropathol, 124, 305, 10.1007/s00401-012-0996-2 · DOI · Paper page
- Skoglund, 2008, The tau S305S mutation causes frontotemporal dementia with parkinsonism, Eur J Neurol, 15, 156, 10.1111/j.1468-1331.2007.02017.x · DOI · Paper page
- Stanford, 2000, Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations, Brain, 123, 880, 10.1093/brain/123.5.880 · DOI · Paper page
- Tacik, 2015, A novel tau mutation in exon 12, p.Q336H, causes hereditary Pick disease, J Neuropathol Exp Neurol, 74, 1042, 10.1097/NEN.0000000000000248 · DOI · Paper page
- Tacik, 2015, A novel tau mutation, p.K317N, causes globular glial tauopathy, Acta Neuropathol, 130, 199, 10.1007/s00401-015-1425-0 · DOI · Paper page
- Tacik, 2017, FTDP-17 with pick body-like inclusions associated with a novel tau mutation, p.E372G, Brain Pathol, 27, 612, 10.1111/bpa.12428 · DOI
- Tacik, 2017, Clinicopathologic heterogeneity in FTDP-17 due to MAPT p.P301L mutation, including a patient with globular glial tauopathy, Neuropathol Appl Neurobiol, 43, 200, 10.1111/nan.12367 · DOI · Paper page
- Tan, 2005, Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration?, Acta Neuropathol, 109, 329, 10.1007/s00401-004-0933-0 · DOI
- Tuite, 2005, Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy, Arch Neurol, 62, 1453, 10.1001/archneur.62.9.1453 · DOI
- Van Deerlin, 2007, Biochemical and pathological characterization of frontotemporal dementia due to a Leu266Val mutation in microtubule-associated protein tau in an African American individual, Acta Neuropathol, 113, 471, 10.1007/s00401-006-0155-8 · DOI
- van Herpen, 2003, Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R, Ann Neurol, 54, 573, 10.1002/ana.10721 · DOI · Paper page
- van Swieten, 2007, Hereditary frontotemporal dementia caused by Tau gene mutations, Brain Pathol, 17, 63, 10.1111/j.1750-3639.2007.00052.x · DOI · Paper page
- van Swieten, 1999, Phenotypic variation in hereditary frontotemporal dementia with tau mutations, Ann Neurol, 46, 617, 10.1002/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I · doi:10.1002/1531-8249(199910)46:4<617::aid-ana10>3.0.co;2-i
- van Swieten, 2007, The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo, J Neuropathol Exp Neurol, 66, 17, 10.1097/nen.0b013e31802c39a4 · DOI · Paper page
- Vanacore, 2001, Epidemiology of progressive supranuclear palsy, European Study Group on Atypical Parkinsonisms. Neurol Sci, 22, 101
- Yokota, 2009, Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions, Acta Neuropathol, 117, 429, 10.1007/s00401-009-0493-4 · DOI
Cited by
Structure-based classification of tauopathies
Shi, Y., Zhang, W., Yang, Y., Murzin, A. G., Falcon, B., Kotecha, A., van Beers, M., Tarutani, A., Kametani, F., Garringer, H. J., et al. (2021) · Nature · doi:10.1038/s41586-021-03911-7 · Cited by 878
“Unlike the sporadic diseases described above, mutations +3/+16 in intron 10 of MAPT give rise to a 4R tauopathy that belongs to the spectrum of inherited FTLD-tau (35-38).”
InfluentialMAPT mutations, tauopathy, and mechanisms of neurodegeneration
Strang, K. H., Golde, T. E., & Giasson, B. I. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0197-x · Cited by 424
Mechanisms of secretion and spreading of pathological tau protein
Brunello, C. A., Merezhko, M., Uronen, R.-L., & Huttunen, H. J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03349-1 · Cited by 304
A walk through tau therapeutic strategies
Jadhav, S., Avila, J., Schöll, M., Kovacs, G. G., Kövari, E., Skrabana, R., Evans, L. D., Kontsekova, E., Malawska, B., de Silva, R., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0664-z · Cited by 290
Molecular Pathogenesis of the Tauopathies
Götz, J., Halliday, G., & Nisbet, R. M. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012936 · Cited by 276
Self-citation
Metadata
- Authors
- Forrest, S. L., Kril, J. J., Stevens, C. H., Kwok, J. B., Hallupp, M., Kim, W. S., Huang, Y., McGinley, C. V., Werka, H., Kiernan, M. C., Götz, J., Spillantini, M. G., Hodges, J. R., Ittner, L. M., & Halliday, G. M.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-12-14
- Volume
- 141
- Issue
- 2
- Pages
- 521-534
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2775738646
- Cited by
- 148
- References
- 24
- FWCI
- 10.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- University of New South Wales
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. https://app.cochat.ai/papers/10.1093/brain/awx328
- The paper
- Forrest, S. L., Kril, J. J., Stevens, C. H., Kwok, J. B., Hallupp, M., Kim, W. S., Huang, Y., McGinley, C. V., Werka, H., Kiernan, M. C., Götz, J., Spillantini, M. G., Hodges, J. R., Ittner, L. M., & Halliday, G. M. (2018). Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Brain. https://doi.org/10.1093/brain/awx328
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.